Abilify, the antipsychotic developed by the Japanese Otsuka Group, is listed as the number four top-selling pharmaceutical, according to the influence.
© 2023 Mad in America Foundation
Abilify, the antipsychotic developed by the Japanese Otsuka Group, is listed as the number four top-selling pharmaceutical, according to the influence.